Group 4 Created with Sketch.

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

Verified and Claimed Account
Medicine Matters oncology
03:40
Play Audio
Add to Playlist
Share Report
Snippets are a new way to share audio!
You can clip a small part of any file to share, add to playlist, and transcribe automatically. Just click the to create your snippet!
Top Snippets - Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)
Found on these Playlists
Best Colin Lindsay Interviews on Podcasts or Audio about Colin Listen to audio about Colin Lindsay. Browse for Colin Lindsay interviews, guest appearances, and call-ins. Make snippets of Colin talking to create audio highlights to share with your friends or embed in related blog posts. Vurbl People: Interviews, Commentary, News, and More
Full Description
Back to Top
Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation –  in patients with locally advanced or metastatic non-small-cell lung cancer. Find more on Medicine Matters oncology More from WCLC 2019